The Power List 2021 – Biopharmaceuticals
Global Head of JLabs at Johnson & Johnson Innovation
Before joining JLABS, Richter was the Founder and CEO of Prescience International, which was dedicated to accelerating research to the patient. Richter created the company after a medical emergency left her questioning the efficiency of the current healthcare system. In her current role, she supports the innovation community by creating capital-efficient commercialization models that help early-stage companies. She is also Board Chair of the California Life Sciences Association and a board member of BIO’s Technology Transfer Committee.
“COVID-19 accelerated trends in the healthcare industry which have and will continue to create more value for everyone. We’ve seen parallel processing in drug development accelerate time to market for life-enhancing, life-saving therapies; collaboration across companies, borders, and types of organizations to meet an urgent health security threat; an increased focus on health equity and diverse clinical trials to bring more potential solutions to people who’ve had marginalized care; and more options to get and cover virtual care outside of traditional institutional offerings. I feel the crisis of COVID-19 demanded creativity, generosity, empathy and pure determination, and each of us played our part.”